AzTrials
AzTrials

ObesityNCT01255085

Yellow Pea Protein and Fibre and Short Term Food Intake

A study testing yellow pea protein and yellow pea fiber in people with Obesity and Type II Diabetes Mellitus, run by University of Toronto at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is hypothesized that yellow pea protein and fiber will reduce short-term food intake, subjective appetite and glycemic response. Read more about this study

Who is it for?
Ages 20 to 29 years, men onlyHealthy volunteers can take part
What is being tested?
yellow pea protein and yellow pea fiber
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteCanada
Study dates
May 2008to Jun 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 29 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • male 20-30 years old healthy weight

Who cannot join

  • smoking restrictive eating metabolic diseases breakfast skippers dieters

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Toronto - Department of Nutritional Sciences

    Toronto, Ontario, M5S 3E2

Other trials in Canada

About this study

Official title: The Effect of Yellow Pea Protein and Fiber on Short Term Food Intake, Subjective Appetite and Glycemic Response in Healthy Young Males

It is hypothesized that yellow pea protein and fiber will reduce short-term food intake, subjective appetite and glycemic response.

Read the detailed description

A within-subject, randomized study was conducted. Each subject returned 5 times, 1 week apart, and received 1 of the 5 treatments per week. The 5 treatments were tomato soup with 10 or 20 g of isolated yellow pea fibre or protein, or a control soup with no added pea fractions. Food intake was measured at an ad libitum pizza meal served 30 minutes after treatment. Satiety and blood glucose (via finger prick) were measured throughout the treatment period.

Being tested
yellow pea protein, yellow pea fiber, Control Tomato Soup
Keywords
Obesity, Food intake regulation, blood glucose regulation, protein, fiber, pulses, yellow peas
Medical subject headings
Obesity, Diabetes Mellitus, Type 2, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • yellow pea proteinDietary supplement

    Served in a tomato soup

  • yellow pea fiberDietary supplement

    Served in a tomato soup

  • Control Tomato SoupDietary supplement

    Served in a tomato soup

Study groups in NCT01255085
Study groupRoleWhat they receive
10 g of yellow pea fiberExperimentalNot described
Receives: Dietary Supplement: yellow pea fiber
20 g of yellow pea fiberExperimentalNot described
Receives: Dietary Supplement: yellow pea fiber
10 g of yellow pea proteinExperimentalNot described
Receives: Dietary Supplement: yellow pea protein
20 g of yellow pea proteinExperimentalNot described
Receives: Dietary Supplement: yellow pea protein
Control Tomato SoupExperimentalNot described
Receives: Dietary Supplement: Control Tomato Soup

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Energy Intake

    Energy intake at an ad libitum pizza meal

    Measured: at 30 minutes after treatment

Secondary outcomes (2)
  1. Glycemic Response

    Blood Glucose every 15-30 minutes via finger prick

    Measured: 0-170 minutes post treatment

  2. Subjective Appetite

    Subjective Appetite measured every 15-30 minutes via Visual Analog Scale (VAS)

    Measured: 0-170 minutes post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Dec 2010 (estimated)
  2. Study startMay 2008
  3. Primary completionAug 2010
  4. Study completionJun 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01255085
Sponsor's protocol ID
PureNet_22627
Status last verified
Jun 2012
First submitted
3 Dec 2010
Last updated
15 Jun 2012
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing yellow pea protein and yellow pea fiber in people with Obesity and Type II Diabetes Mellitus, run by University of Toronto at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Energy Intake (time frame: at 30 minutes after treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in